Clinical • P2 data • Combination therapy • PD(L)-1 Biomarker • IO biomarker
|
NT5E (5'-Nucleotidase Ecto) • TGFB1 (Transforming Growth Factor Beta 1)
|
CD73 expression
|
gemcitabine • 5-fluorouracil • albumin-bound paclitaxel • balstilimab (AGEN2034) • dalutrafusp alfa (AGEN1423)